Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 224,361
  • Shares Outstanding, K 51,696
  • Annual Sales, $ 79,870 K
  • Annual Income, $ -51,510 K
  • EBIT $ -50 M
  • EBITDA $ -48 M
  • 60-Month Beta 2.46
  • Price/Sales 2.63
  • Price/Cash Flow N/A
  • Price/Book 2.70

Options Overview Details

View History
  • Implied Volatility 160.18% ( -84.24%)
  • Historical Volatility 62.77%
  • IV Percentile 44%
  • IV Rank 13.29%
  • IV High 1,087.56% on 03/06/25
  • IV Low 18.03% on 09/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 245
  • Open Int (30-Day) 261

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.32
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.19 +33.54%
on 05/28/25
4.46 -4.40%
on 06/24/25
+1.06 (+33.13%)
since 05/23/25
3-Month
2.03 +109.85%
on 04/08/25
4.46 -4.40%
on 06/24/25
+1.19 (+38.76%)
since 03/24/25
52-Week
2.03 +109.85%
on 04/08/25
8.45 -49.59%
on 07/24/24
-1.91 (-30.96%)
since 06/24/24

Most Recent Stories

More News
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

SGHT : 4.26 (-1.84%)
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

SGHT : 4.26 (-1.84%)
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

SGHT : 4.26 (-1.84%)
Sight Sciences Announces the Release of its Sustainability Report

SGHT : 4.26 (-1.84%)
Sight Sciences Appoints Gary Burbach to its Board of Directors

SGHT : 4.26 (-1.84%)
LAB : 1.2200 (-0.81%)
BWXT : 142.31 (+0.18%)
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

SGHT : 4.26 (-1.84%)
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

SGHT : 4.26 (-1.84%)
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

SGHT : 4.26 (-1.84%)
Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

SGHT : 4.26 (-1.84%)
Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

SGHT : 4.26 (-1.84%)

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 4.67
2nd Resistance Point 4.56
1st Resistance Point 4.41
Last Price 4.26
1st Support Level 4.15
2nd Support Level 4.05
3rd Support Level 3.90

See More

52-Week High 8.45
Fibonacci 61.8% 6.00
Fibonacci 50% 5.24
Fibonacci 38.2% 4.48
Last Price 4.26
52-Week Low 2.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar